Get the Stockscreener App
126.00
4.06%
-5.54
Transmedics Group Inc stock is traded at $126.00, with a volume of 1.00M.
It is down -4.06% in the last 24 hours and up +9.08% over the past month.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
See More
Previous Close:
$131.54
Open:
$128.48
24h Volume:
1.00M
Relative Volume:
0.99
Market Cap:
$4.30B
Revenue:
$531.29M
Net Income/Loss:
$71.66M
P/E Ratio:
65.16
EPS:
1.9338
Net Cash Flow:
$17.35M
1W Performance:
-4.72%
1M Performance:
+9.08%
6M Performance:
+40.25%
1Y Performance:
+53.16%
1-Day Range:
$119.20
$131.55
1-Week Range:
$119.20
$140.87
52-Week Range:
$55.00
$145.50
Transmedics Group Inc Stock (TMDX) Company Profile
Name
Transmedics Group Inc
Sector
Industry
Phone
(978) 552-0900
Address
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
126.08 | 4.50B | 531.29M | 71.66M | 17.35M | 1.9338 |
|
ABT
Abbott Laboratories
|
123.50 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.93 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.74 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
89.84 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.90 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-23-25 | Upgrade | Needham | Hold → Buy |
| Oct-13-25 | Initiated | Jefferies | Buy |
| Sep-16-25 | Initiated | Evercore ISI | Outperform |
| Sep-04-25 | Initiated | Stifel | Hold |
| Dec-17-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-22-24 | Downgrade | Needham | Buy → Hold |
| Oct-29-24 | Reiterated | Needham | Buy |
| Oct-29-24 | Reiterated | Oppenheimer | Outperform |
| Sep-24-24 | Initiated | Robert W. Baird | Outperform |
| Aug-21-24 | Initiated | Needham | Buy |
| Jun-06-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-04-24 | Initiated | Stephens | Overweight |
| Mar-28-24 | Initiated | Piper Sandler | Overweight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Aug-02-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-08-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-07-20 | Initiated | Oppenheimer | Outperform |
| May-28-19 | Initiated | Canaccord Genuity | Buy |
| May-28-19 | Initiated | Cowen | Outperform |
| May-28-19 | Initiated | JP Morgan | Overweight |
| May-28-19 | Initiated | Morgan Stanley | Equal-Weight |
View All
Transmedics Group Inc Stock (TMDX) Latest News
Why TransMedics Group Inc. stock is trending among retail tradersMarket Trend Summary & Verified Swing Trading Watchlists - newser.com
Wakefield Asset Management LLLP Makes New Investment in TransMedics Group, Inc. $TMDX - MarketBeat
Will TransMedics Group Inc. stock split again soonWeekly Gains Report & Low Risk Entry Point Tips - newser.com
What institutional flow reveals about TransMedics Group Inc.Weekly Gains Summary & Free Technical Pattern Based Buy Signals - newser.com
How interest rate cuts could boost TransMedics Group Inc. stockEarnings Growth Report & Real-Time Chart Breakout Alerts - newser.com
Is TransMedics Group Inc. stock near bottom after declineChart Signals & High Conviction Buy Zone Picks - newser.com
Can TransMedics Group Inc. stock maintain operating margins2025 Breakouts & Breakdowns & Growth Oriented Trading Recommendations - newser.com
Montanaro Asset Management Ltd Trims Holdings in TransMedics Group, Inc. $TMDX - MarketBeat
Detecting support and resistance levels for TransMedics Group Inc.Weekly Gains Report & AI Driven Price Forecasts - newser.com
Can TransMedics Group Inc. rally from current levelsWeekly Trade Recap & Free Community Consensus Stock Picks - newser.com
How TransMedics Group Inc. stock responds to policy changesQuarterly Portfolio Review & Entry Point Confirmation Signals - newser.com
Technical signs of recovery in TransMedics Group Inc.Market Performance Report & AI Based Trade Execution Alerts - newser.com
Is TransMedics Group Inc. stock overvalued by current metricsJuly 2025 Snapshot & Free Technical Pattern Based Buy Signals - newser.com
Will TransMedics Group Inc. stock outperform value stocksStock Surge & Weekly Sector Rotation Insights - newser.com
Published on: 2025-11-02 22:23:53 - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
TransMedics Group Inc. stock trendline breakdown2025 Trading Volume Trends & Weekly Top Gainers Alerts - newser.com
Spire Wealth Management Makes New $679,000 Investment in TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics Group’s Earnings Call Highlights Robust Growth and Strategic Expansion - MSN
Edward Basile Sells 4,142 Shares of TransMedics Group (NASDAQ:TMDX) Stock - MarketBeat
What candlestick patterns are forming on TransMedics Group Inc.Swing Trade & Free Expert Verified Stock Movement Alerts - newser.com
How TransMedics Group Inc. stock performs in rate cut cycles2025 Technical Patterns & AI Driven Price Predictions - newser.com
Can TransMedics Group Inc. stock hit analyst price targetsTrade Signal Summary & Free Real-Time Market Sentiment Alerts - newser.com
Chart overlay techniques for tracking TransMedics Group Inc.July 2025 WrapUp & AI Powered Buy/Sell Recommendations - newser.com
TransMedics Group, Inc. (NASDAQ:TMDX) Q3 2025 Earnings Call Transcript - MSN
Retail Traders Swarm TransMedics After Q3 Print— Retail Bulls Call It A ‘Hardcore Dip Buy’ - Stocktwits
TransMedics director exercises 4,142 options, sells shares same day - Stock Titan
Operating cash flow per share of TransMedics Group, Inc. – BX:TMDX - TradingView
TransMedics Group, Inc. (TMDX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
TransMedics (NASDAQ: TMDX) grants options at $132.45 exercise price to 15 - Stock Titan
TransMedics: Growth Tailwinds Should Provide Upside In 2026 (NASDAQ:TMDX) - Seeking Alpha
TransMedics Group, Inc. $TMDX Shares Sold by Emerald Mutual Fund Advisers Trust - MarketBeat
TransMedics Group (NASDAQ:TMDX) Price Target Cut to $140.00 by Analysts at Piper Sandler - MarketBeat
Here's Why TransMedics (TMDX) is a Strong Growth Stock - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: MiMedx Group (MDXG), TransMedics Group (TMDX) and Arcus Biosciences (RCUS) - The Globe and Mail
Should you wait for a breakout in TransMedics Group Inc.Quarterly Market Summary & Daily Oversold Stock Bounce Ideas - newser.com
Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN), TransMedics Group (TMDX) and Opko Health (OPK) - The Globe and Mail
TransMedics Group (TMDX): Assessing Valuation After Strong Q3 Results and Upgraded Growth Outlook - Yahoo Finance
Analysts Are Bullish on Top Healthcare Stocks: TransMedics Group (TMDX), Nuvalent (NUVL) - The Globe and Mail
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Sahm
Transmedics Group Inc Stock (TMDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Transmedics Group Inc Stock (TMDX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Basile Edward M | Director |
Oct 29 '25 |
Sale |
130.45 |
4,142 |
540,324 |
2,866 |
2.30%
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):